Evidence demonstrates that the NLRP3 inflammasome modulates the phenotype and proliferation rate of vascular smooth muscle cells in hypertension [150] and that the activation of the NLRP3 inflammasome in these conditions is triggered by increased cytosolic Ca2+ mediated by the calcium-sensing receptor CaSR [151]. This evidence concerns the gene NLRP3 and hypertensive disorder.